Open access · CC-BY
via OpenAlex
PF-05231023, a long-acting FGF21 analogue, decreases body weight by reduction of food intake in non-human primates
W. Clayton Thompson, Yingjiang Zhou, Saswata Talukdar, Cynthia J. Musante
Journal of Pharmacokinetics and Pharmacodynamics · 2016 · ▲ 49 citations
Abstract
PF-05231023, a long-acting FGF21 analogue, is a promising potential pharmacotherapy for the treatment of obesity and associated comorbidities. Previous studies have shown the potential of FGF21 and FGF21-like compounds to decrease body weight in mice, non-human primates, and humans; the precise mechanisms of action remain unclear. In particular, there have been conflicting reports on the degree to which FGF21-induced weight loss in non-human primates is attributable to a decrease in food intake versus an increase in energy expenditure. Here, we present a semi-mechanistic mathematical model of energy balance and body composition developed from similar work in mice. This model links PF-05231023 administration and washout to changes in food intake, which in turn drives changes in body weight. The model is calibrated to and compared with recently published data from cynomolgus macaques treated with PF-05231023, demonstrating its accuracy in describing pharmacotherapy-induced weight loss in these animals. The results are consistent with the hypothesis that PF-05231023 decreases body weight in cynomolgus macaques solely by a reduction in food intake, with no direct effect on energy expenditure.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1007/s10928-016-9481-1
- Canonical
- link ↗
- Fetched
- 2026-07-15 MST
Cite this
APA
Thompson, W.C., Zhou, Y., Talukdar, S., & Musante, C.J. (2016). PF-05231023, a long-acting FGF21 analogue, decreases body weight by reduction of food intake in non-human primates. <em>Journal of Pharmacokinetics and Pharmacodynamics</em>. https://doi.org/10.1007/s10928-016-9481-1
Vancouver
Thompson WC, Zhou Y, Talukdar S, Musante CJ. PF-05231023, a long-acting FGF21 analogue, decreases body weight by reduction of food intake in non-human primates. Journal of Pharmacokinetics and Pharmacodynamics. 2016. doi:10.1007/s10928-016-9481-1.
BibTeX
@article{w2016PFalon,
title = {PF-05231023, a long-acting FGF21 analogue, decreases body weight by reduction of food intake in non-human primates},
author = {W. Clayton Thompson and Yingjiang Zhou and Saswata Talukdar and Cynthia J. Musante},
journal = {Journal of Pharmacokinetics and Pharmacodynamics},
year = {2016},
doi = {10.1007/s10928-016-9481-1},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
American Journal of Clinical Nutrition 2002
Open access · OA
Betaine supplementation decreases plasma homocysteine concentrations but does not affect body weight, body composition, or resting energy expenditure in human subjects,,
Current Opinion in Endocrinology Diabetes and Obesity 2010
Citation only
Testosterone and type 2 diabetes
Springer eBooks 2024
Citation only
Epigenetic Changes in Aging: The Contribution of SIRT1 to Longevity
Journal of Nutrition 2007
Open access · OA
Energy Restriction-Induced Changes in Body Composition Are Age Specific in Mice , ,3
Nutrients 2022
Open access · CC-BY
Effects of Intermittent Fasting on Cardiometabolic Health: An Energy Metabolism Perspective
Scientific Reports 2018
Open access · CC-BY